Follicular Lymphoma Patients (Phase IB)
1 clinical trials · Condition
◉ Watch Follicular Lymphoma Patients (Phase IB)
| Record | Firm | Date |
|---|---|---|
| Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell Lymphoma (NCT01582776) | The Lymphoma Academic Research Organisation | 2012-10-03 |
Track Follicular Lymphoma Patients (Phase IB) automatically
Every clearance here is in the API, with alerts when new ones post.